There is no denying the road is not easy and the Heartmate story is proof.
But there is a need out there for devices of this type to keep people alive and the Ventrassist is proving to be the most advanced of it's type.
Management are right to think(barring unforseen disasters)that their product will be the prefferred product on market in the foreseeable future,and until a better comes along will rule the roost.
So as long as Ventracor keep improving their device the rest have to play catch up and go through the same criteria as VCR is going through at the moment with no guarantees of their product being a success.
Bring leader of the pack especially when acceptance is fast being accepted by the medical fraternaty that this is the optimum treatment for improving the outcomes for end heart failure is a huge plus.
- Forums
- ASX - By Stock
- VCR
- gonna pull a trick
VCR
ventracor limited
gonna pull a trick, page-21
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)